Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating renal dysfunction based on perlecan as a biomarker

Method of treating renal dysfunction based on perlecan as a biomarker

US Patent 8501418 · Granted Aug 6, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of aptamers in proteomics2024
Use of aptamers in proteomics2023
Use of aptamers in proteomics2021
Use of aptamers in proteomics2019
Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and 2018
MCAM as a biomarker for fluid homeostasis2018
Biomarkers for hypertensive disorders of pregnancy2017
Use of aptamers in proteomics2017
Method to determine treatment of acute heart failure2017
Method to determine treatment of acute heart failure2017
Method to determine treatment of acute heart failure2017
Perlecan as a biomarker for renal dysfunction2016